SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

October 27, 2014 10:34 ET

MMRGlobal Cracks the Code on Electronic Medical Records Interoperability

LOS ANGELES, CA--(Marketwired - Oct 27, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) and its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"), was profiled in Breitbart News today (http://goo.gl/8TFxFr). MMR is a health information technology company whose primary business is Electronic Medical Records with an emphasis on the Personal Health Record ("PHR") market. MMR sells its proprietary interoperable MyMedicalRecords Personal Health Record Kit available directly online and at retailers everywhere. MyMedicalRecords enables patients and their family the ability to securely access, manage and control their protected health information. An October 21st story entitled "Ebola Patient's Electronic Medical Records 'Glitch' Casts Light on $25 Billion Obama Stimulus Boondoggle" highlighted the MyMedicalRecords PHR. Since its release, and as of yesterday, the story continues to be the highest ranking "Electronic Medical Records" story on Google Search -- above "Electronic Medical Records" in The New York Times. The Company attributes this to consumer interest in securely managing and controlling access to their personal health information from all of their medical providers in one convenient place. The MyMedicalRecords PHR also includes built-in automated reminders which can be programmed to take your medication, take your blood pressure, check your insulin, and in the wake of the Ebola outbreak, take your temperature. The Personal Health Record also includes an emergency access portal to share patient-controlled medical records with physicians and first responders in the event of an emergency or natural disaster as featured in a nationally syndicated television commercial that can be seen at https://www.youtube.com/watch?v=MF5P2tOoSE4&feature=youtu.be.

MMRGlobal focuses on offering its MyMedicalRecords PHR and patient empowerment tools designed to enable families to securely access and control their medical records with a side benefit of helping patients reduce their medical costs. Additionally, MMR owns worldwide portfolios of numerous health information technology patents covering amongst other things Personal Health Record products and services as well as technology to track patient information for use with Electronic Health Record systems in Clinical Trials.

Today's profile, entitled MMRGlobal Allows Patients to Crack the Code on Electronic Medical Records Interoperability, stated ...."Healthcare experts say a vexing problem that puts patients at risk is playing out nationally: the computer systems American hospitals and doctors' offices use to send and store a patient's medical records can't talk to one another. Worse, when Americans travel overseas on business or vacation, the problem morphs from frustrating to dire, as foreign hospitals and doctors have no way of accessing vital, potentially life-saving Personal Health Records.

Analysts and health information technology experts in the booming Electronic Medical Records industry say breaking through the "interoperability" barrier -- the ability for Electronic Medical Records systems to seamlessly communicate with each other -- will take years. Last month, the Office of the National Coordinator for Health Information Technology told the New York Times modernizing America's health tech infrastructure to achieve interoperability will take at least a decade.

Enter industry disruptor MMRGlobal, an emerging publicly traded company (MMRF) that has created a system called MyMedicalRecords that allows patients to store all their personal health information in a secure Personal Health Record online "vault" that can be accessed anywhere, anytime. MMRGlobal's proprietary, patented technology is poised to benefit from the growth and valuations in the eHealth industry. Their MyMedicalRecords Personal Health Record (PHR) has already caught the eye of employee benefits managers, affinity groups, and retailers like Walgreens.com and drugstore.com, both of whom now carry a MyMedicalRecords Personal Health Record Kit.

"Since 2005, MyMedicalRecords has been focused on giving patients the ability to access their medical records from any healthcare provider, from anywhere in the world, regardless of the system used whether electronic or plain paper. With more than 25 billion dollars of government stimulus monies already paid to eligible hospitals and healthcare professionals over the past three years, patients are now being told they could wait another 10 years before the nation's labyrinthine hospital computer nightmare is untangled. "That is why we built a secure, portable, easy-to-use solution that empowers patients to take control of their health information in real time, especially in an emergency," said MMRGlobal Chairman and CEO Bob Lorsch.

The MyMedicalRecords Personal Health Record Kit gives customers a user-friendly solution to authorize doctors and hospitals using any Electronic Medical Records system to "deposit" protected health information for an entire family directly into a patient's encrypted MyMedicalRecords "vault." Users receive an alert when new records are received into their account in any number of secure ways, as well as through a dedicated "Lifeline" telephone number that connects with a special Emergency Login. This separate emergency portal makes patient-controlled, potentially life-saving health information accessible to medical personnel and first responders in an emergency or natural disaster. Each MyMedicalRecords Personal Health Record account allows users to store the health records of up to 10 family members, including veterinary records for pets.

MMR believes its MyMedicalRecords patented technology, ease-of-use for patients and doctors, and portability make it poised to exploit the void created by the lack of interoperability within the world's health IT market, projected to reach more than $162 billion by 2015.

MMRGlobal's growth trajectory is fueled in part by the company's aggressive and robust patent portfolio. Since inception, MMR's health IT Patent Portfolio has grown to include 13 issued U.S. patents with over 300 claims and additional and continuing applications, bringing the total to over 600 claims. The company also has issued patents and pending applications in 11 other countries or regional authorities of commercial interest, including: Australia, Singapore, New Zealand, China, Mexico, Canada, Japan, Hong Kong, South Korea, Israel, and Europe.

In addition to serving individual customers, MMR also provides services as employee benefits to numerous employers and professional organizations. The company has also expanded into the patient care space with its development of MMRPro, a SaaS application that gives small-to-mid-size physicians' offices a cost-effective, easy-to-use solution for digitally capturing, storing, and sharing records and images.

"The future of the Personal Health Records industry is all about providing individuals and families with an affordable, portable, easy-to-use system that gives them control by enabling access to all their medical records and other important documents in one secure place," says Lorsch. "That's exactly what MyMedicalRecords.com has done. And that is why we believe our product is a cost-effective solution to closing the nation's Electronic Medical Record interoperability gap for patients."

In addition to being a practicing entity as a leading provider of Personal Health Records, MyMedicalRecords, Inc. has a health IT patent portfolio that currently consists of 13 issued U.S. patents, 17 pending U.S. applications, and numerous issued patents and pending applications in other countries or regional authorities of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel and Europe. MMR's U.S. patents include U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. The most recently issued U.S. patent, U.S. Patent No. 8,775,212, represents MMR's first Clinical Trials patent and includes 18 claims directed to methods and systems that provide for self-reporting being used to create Electronic Health Records for purposes including Clinical Trials. Although the Company's primary focus is as a provider and licensor of health IT products and services, it also has a growing list of patents related to cancer-fighting anti-CD20 monoclonal antibodies under the title, "Antibodies and Methods For Making and Using Them," issued in the U.S., Mexico, Australia and South Korea, with patents pending in Australia, Brazil, Canada, China, Hong Kong, India, Europe, Japan and Korea. MMR also holds additional patents pertaining to its B-cell idiotype vaccine worldwide.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Follow us on Facebook.com/MMRGlobal and Twitter.com/mmrglobal.

About Breitbart News
Breitbart News is a leading news website that provides continuously updated headlines and original reporting throughout the day to top news and information around the globe.

Forward-Looking Statements
 
All statements in this release that are not strictly historical facts are "forward-looking statements." Such forward-looking statements are based on MMR's current assumptions, beliefs and expectations, and involve risks, uncertainties and other factors that may cause MMR's actual results to be materially different from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words such as "expect," "plan," "possibility," "offer," "if," "negotiate," "when," "believe," "will," "estimate," "continue," and similar expressions. Risks, uncertainties, and other factors that could cause or contribute to such differences include, but are not limited to: ongoing and future intellectual property enforcement actions; the ability to successfully litigate or settle claims of patent infringement; MMR's ability to develop, license and monetize its patents in the portfolio for both MMR's health IT and biotechnology IP assets; the timing of milestone payments in connection with licensing its IP; reliance upon the successful operations of its business partners in selling MMR's products and services; MMR's ability to obtain necessary financing, generate sufficient cash flow, and maintain appropriate indebtedness; and the increasing development of market competition in the area of electronic records in clinical trials. These factors and others are described in more detail in MMR's public filings with the Securities and Exchange Commission, including the risks discussed in the "Risk Factors" section in MMR's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of these reports can be found on MMR's website (www.mmrglobal.com) under the heading "Investor Relations." MMR is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Contact Information